Bloomberg Merck & Co.’s cancer treatment Keytruda was almost twice as successful at shrinking lung cancer tumors than a standard chemotherapy regimen, a study of the drug in previously untreated patients found. In the 123-patient study, 55 percent of those on Keytruda plus two chemotherapy drugs saw their tumors get smaller, compared with 29 percent on just the chemotherapy ...

  Bloomberg Unlike many pension investors, Sweden’s 300 billion-krona ($34 billion) AP7 fund, can to a large extent stay away from the bond markets. It’s manager, Richard Grottheim, is remarkably positive. As political risk mounts in Europe and the U.S., and as central banks are greasing financial markets with ever more free cash, Grottheim says it will likely all work ...

  Will Brexit be hard or soft? The question preoccupies British politicians and commentators — not to mention global currency markets, if the sharp fall in sterling this week is any guide. Despite its command of the discussion, however, this hard-or-soft framing is unhelpful. It’s best dropped altogether. Sterling slumped after Prime Minister Theresa May announced on Oct. 2 that ...